Article citationsMore>>

Siemeister, G., Lücking, U., Wengner, A.M., Lienau, P., Steinke, W., Schatz, C., Mumberg, D. and Ziegelbauer, K. (2012) BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application. Molecular Cancer Therapeutics, 11, 2265-2273.
https://doi.org/10.1158/1535-7163.MCT-12-0286

has been cited by the following article: